Physician profile
Kevin Murphy
NPI 1285666982
$5,413.03
in general payments reported to CMS, 2019-2025
23 companies · $228 in 2025
The $228 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,509 · 2020: $135 · 2021: $637 · 2022: $226 · 2023: $349 · 2024: $330 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $3,326.86 | 2019-2021 | |
| Pfizer INC. | $488.01 | 2019-2025 | |
| Glaxosmithkline, LLC. | $381.35 | 2019-2024 | Rotarix, Bexsero |
| Supernus Pharmaceuticals, INC. | $218.79 | 2021 | |
| Merck Sharp & Dohme LLC | $166.76 | 2019-2025 | Vaxelis, Gardasil 9, Enflonsia |
| Hologic Sales and Service, LLC | $129.99 | 2022-2025 | Aptima |
| Cranial Technologies, INC | $117.60 | 2024-2025 | Doc Band |
| Seqirus USA INC | $114.19 | 2021-2024 | Flucelvax, Flucelvax Quadrivalent |
| Kaleo, INC. | $80.54 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $73.29 | 2021-2022 | |
| Shire North American Group INC | $36.52 | 2019 | |
| Alk-Abello, INC | $30.18 | 2025 | Neffy |
| Mayne Pharma Commercial LLC | $29.62 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $29.05 | 2023 | |
| Masimo Corporation | $26.50 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $24.69 | 2021 | |
| Sobi, INC | $23.42 | 2023 | |
| Corium, LLC | $22.40 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.84 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.48 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $17.89 | 2021 | |
| Dermira, INC. | $17.77 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.29 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.